Eumycetoma Medical Treatment: Past, Current Practice, Latest Advances and Perspectives

Siddig, Emmanuel Edwar and Ahmed, Ayman and Ali, Yousif and Bakhiet, Sahar Mubarak and Mohamed, Nouh Saad and Ahmed, Eiman Siddig and Fahal, Ahmed Hassan (2021) Eumycetoma Medical Treatment: Past, Current Practice, Latest Advances and Perspectives. Microbiology Research, 12 (4). pp. 899-906. ISSN 2036-7481

[thumbnail of microbiolres-12-00066-v2.pdf] Text
microbiolres-12-00066-v2.pdf - Published Version

Download (288kB)

Abstract

Mycetoma is a neglected tropical disease that is associated with poor communities and socioeconomically impaired individuals in the tropical and sub-tropical areas. Interestingly, the disease is caused by either bacteria (actinomycetoma) or fungus (eumycetoma). The latter form of the disease, eumycetoma, is the most common type in Africa. Eumycetoma is characterized by a prolonged disease duration and low cure rate. The effective case management of eumycetoma largely depends on the accurate diagnosis and identification of the causative agent to the species level and evaluating its susceptibility to the available drugs. This review summarizes the currently available and used antifungal agents for the treatment of eumycetoma and discusses optimizing the newly developed antifungals as a potential second line for eumycetoma treatment.

Item Type: Article
Subjects: Open Archive Press > Medical Science
Depositing User: Unnamed user with email support@openarchivepress.com
Date Deposited: 16 Jun 2023 05:14
Last Modified: 30 Mar 2024 04:04
URI: http://library.2pressrelease.co.in/id/eprint/1553

Actions (login required)

View Item
View Item